Penalties and Rewards for Safety Net vs Non-Safety Net Hospitals in the First 2 Years of the Comprehensive Care for Joint Replacement Model

Funding

Corresponding Author: Caroline P. Thirukumaran, MBBS, MHA, PhD, Department of Orthopaedics, University of Rochester, 601 Elmwood Ave, Box 665, Rochester, NY 14642 ([email protected]). Author Contributions: Dr Thirukumaran had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. Concept and design: Thirukumaran, Glance, Cai, Li. Acquisition, analysis, or interpretation of data: All authors. Drafting of the manuscript: Thirukumaran. Critical revision of the manuscript for important intellectual content: All authors. Statistical analysis: Thirukumaran, Glance, Cai, Kim. Obtained funding: Thirukumaran. Administrative, technical, or material support: Thirukumaran. Supervision: Thirukumaran, Li. Conflict of Interest Disclosures: Drs Cai and Li reported receipt of grant funding from the National Institutes of Health. Dr Li also reported receipt of personal fees from Springer, Boston Consulting Group Inc, and Intermountain Healthcare. No other disclosures were reported. Funding/Support: All authors receive funding support from the National Institute on Minority Health and Health Disparities of the National Institutes of Health under award number R01MD012422. Role of the Funder/Sponsor: The funding agency had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; or decision to submit the manuscript for publication. Disclaimer: This content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Additional Contributions: We thank Leonce Nshuti, MSc (Department of Health Policy, Vanderbilt University School of Medicine), for programming assistance related to this project. His salary is supported by the Commonwealth Fund and the Leukemia and Lymphoma Society. Conflict of Interest Disclosures: Dr Dusetzina reported being a member of the Institute for Clinical and Economic Review’s Midwest Comparative Effectiveness Public Advisory Council and serving on the National Academy of Sciences, Engineering, and Medicine Committee’s Ensuring Patient Access to Affordable Drug Therapies. Dr Dusetzina also reported receiving grants from the Commonwealth Fund, Leukemia and Lymphoma Society, and Laura and John Arnold Foundation. Drs Huskamp and Keating reported receiving grants from the Commonwealth Fund and the Leukemia and Lymphoma Society.